Revvity Inc. (NYSE:RVTY) Plans Quarterly Dividend of $0.07

Revvity Inc. (NYSE:RVTY) declared a quarterly dividend on Friday, July 31st. Stockholders of record on Friday, October 23rd will be given a dividend of $0.07 per share on Friday, November 13th. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd.

Revvity has a payout ratio of 5.1% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Revvity to earn $5.92 per share next year, which means the company should continue to be able to cover its $0.28 annual dividend with an expected future payout ratio of 4.7%.

Revvity Trading Up 0.4%

NYSE RVTY traded up $0.58 during trading on Wednesday, reaching $156.59. 196,077 shares of the stock traded hands, compared to its average volume of 1,502,536. The firm has a market cap of $17.47 billion, a price-to-earnings ratio of 74.40, a price-to-earnings-growth ratio of 2.75 and a beta of 1.06. The stock’s 50-day moving average price is $137.99 and its 200 day moving average price is $114.56. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. Revvity has a fifty-two week low of $81.22 and a fifty-two week high of $166.25.

Revvity (NYSE:RVTY) last issued its earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, beating the consensus estimate of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The firm had revenue of $729.69 million during the quarter, compared to the consensus estimate of $702.96 million. During the same quarter in the prior year, the firm earned $1.18 earnings per share. The business’s quarterly revenue was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Analysts predict that Revvity will post 5.36 EPS for the current year.

About Revvity

Revvity, Inc provides technology, products and services for the life sciences and diagnostics markets. The company supports pharmaceutical and biotechnology research, clinical laboratories and other healthcare organizations with tools used in drug discovery, biological research, disease detection and laboratory testing.

Its offerings include laboratory instruments, reagents, consumables, software and workflow solutions. Key areas include genomics, proteomics, cellular analysis, imaging, screening, automation and reproductive health, as well as newborn screening and other diagnostic applications.